Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study

Immunocompromised patients with hematologic malignancies are more susceptible to COVID-19 and at higher risk of severe complications and worse outcomes compared with the general population. In this context, we evaluated the humoral response by determining the titers of neutralizing antibodies (NAbs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavriatopoulou, Maria, Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Briasoulis, Alexandros, Gumeni, Sentiljana, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Eleutherakis-Papaiakovou, Evangelos, Kanellias, Nikolaos, Kastritis, Efstathios, Trougakos, Ioannis P., Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450138/
https://www.ncbi.nlm.nih.gov/pubmed/34529762
http://dx.doi.org/10.1182/bloodadvances.2021005444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450138/
https://www.ncbi.nlm.nih.gov/pubmed/34529762
http://dx.doi.org/10.1182/bloodadvances.2021005444

Ejemplares similares